SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pediatric Oncology Nursing
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lovett, R. B.
Right arrow Articles by McMillan, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lovett, R. B.
Right arrow Articles by McMillan, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Validity and Reliability of a Pediatric Hematology Oncology Patient Acuity Tool

Ruth Busch Lovett, RN, MS, CNAA

H. Lee Moffitt Cancer Center & Research Institute, and College of Nursing, University of South Florida, Tampa, FL

Leslie Wagner, RN, MSN

H. Lee Moffitt Cancer Center & Research Institute, and College of Nursing, University of South Florida, Tampa, FL

Susan McMillan, PhD, RN

H. Lee Moffitt Cancer Center & Research Institute, and College of Nursing, University of South Florida, Tampa, FL

Appropriate use of nursing resources in the pediatric hematology and oncology inpatient settings demands a patient acuity system that is easy to use and accurate, and that objectively measures nursing care needs of a specialized patient population. Structured survey of 13 comprehensive cancer centers and a review of the literature show no valid and reliable acuity tools for this pediatric population. The purpose of this project was to study the validity and reliability of a newly developed pediatric hematology and oncology acuity system designed to quantify patient care needs. A new acuity tool for this pediatric population was developed based on the patient classification tool used at Johns Hopkins Hospital Oncology Center (JHHOC). The levels of care from the JHHOC tool were adopted, with therapeutic indicators modified to reflect nursing diagnoses relevant to the pediatric inpatient. Nursing care hours required for each level of care were also identified. Validity was studied using a content validity index (CVI). Experts from the pediatric unit where the tool would be used were asked whether each therapeutic indicator was assigned to the correct level of care (1 thru 5) based on patient care hours. CVIs for items ranged from .5 to 1.0; the overall CVI for the tool was .93. Interrater reliability was studied using two raters from the unit. Data were collected for 150 patient observations on a 12-bed pediatric hematology and oncology inpatient and short-stay outpatient unit. The resulting Pearson correlation coefficient was r = .97 (P <.001). The resulting tool is nursing diagnoses based, interfaces with standard care plans, is easy to use, requires no calculation, and provides reliable quantification of nursing work load based on pediatric hematology and oncology patients care needs. Data from this acuity tool determine variable nursing hours per patient per day and assist with patient assignments, staffing and scheduling decisions, budgetary processes, establishing productivity, and will ultimately facilitate establishing charges for nursing services to patients. Currently, a quality assurance interrater reliability design audit system is used to maintain and monitor ongoing integrity and accuracy of the classification system. CVI and interrater reliability studies will occur at regular intervals to ensure the validity and reliability of the tool.

Journal of Pediatric Oncology Nursing, Vol. 8, No. 3, 122-130 (1991)
DOI: 10.1177/104345429100800305


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
D. C. Classen, S. L. Pestotnik, R. S. Evans, J. F. Lloyd, and J. P. Burke
Adverse Drug Events in Hospitalized Patients: Excess Length of Stay, Extra Costs, and Attributable Mortality
JAMA, January 22, 1997; 277(4): 301 - 306.
[Abstract] [PDF]



Advertisement